APA

Ortega J. J., Ribera J. M., Oriol A., Bastida P., González M. E., Calvo C., Egurbide I., Hernández Rivas J. M., Rivas C., Alcalá A., Besalduch J., Maciá J., Gardella S., Carnero M., Lite J. M., Casanova F., Martinez M., Fontanillas M., Feliu E. & San Miguel J. F. (20020102). Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. : Haematologica.

Chicago

Ortega J J, Ribera J M, Oriol A, Bastida P, González M E, Calvo C, Egurbide I, Hernández Rivas J M, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite J M, Casanova F, Martinez M, Fontanillas M, Feliu E and San Miguel J F. 20020102. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. : Haematologica.

Harvard

Ortega J. J., Ribera J. M., Oriol A., Bastida P., González M. E., Calvo C., Egurbide I., Hernández Rivas J. M., Rivas C., Alcalá A., Besalduch J., Maciá J., Gardella S., Carnero M., Lite J. M., Casanova F., Martinez M., Fontanillas M., Feliu E. and San Miguel J. F. (20020102). Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. : Haematologica.

MLA

Ortega J J, Ribera J M, Oriol A, Bastida P, González M E, Calvo C, Egurbide I, Hernández Rivas J M, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite J M, Casanova F, Martinez M, Fontanillas M, Feliu E and San Miguel J F. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. : Haematologica. 20020102.